Home »

Under Appreciated Tekmira Starting to Bounce May Head Higher as Sector Heats Up

LOS ANGELES, CA — (Marketwire) — 01/31/13 — Immediately after Tekmira (NASDAQ: TKMR) (TSX: TKM) announced that it had settled litigation between it and Alnylam Pharmaceuticals, Byron Capital analyst Douglas Loe maintained his SPECULATIVE BUY rating on the company, but raised his price target on shares a full $5 to $12.50.That was only a couple of months ago, but shares are still trading under $5. This despite the fact that Tekmira announced (within ten days) as part of that settlement and i


© 2021 88Finance. All Rights Reserved. Log in

- Copyright by LayerMedia

Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de